Clinical Trial

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated July 1, 2025 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.
Summary
To Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults after taking the drugs with food (fed state).
Trial Details
NCT Number NCT07044765
Lead Sponsor AJU Pharm Co., Ltd.
Conditions Type2 Diabetes Mellitus
Enrollment 32 participants
Start Date 2025-08
Primary Completion 2025-11 (estimated)
Study Completion 2025-11 (estimated)
Updated on ClinicalTrials.gov 2025-07-01